Deutsche Bank
HRTX icon

Deutsche Bank’s Heron Therapeutics HRTX Stock Holding History

Deutsche Bank’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-520
Closed -$8K – 4683
2021
Q1 		$8K Buy
+520
New +$9.27K ﹤0.01% 4446

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Deutsche Bank's HRTX Position: Q2 2026 in Review

Deutsche Bank increased its Heron Therapeutics (HRTX) stake by 3.5% in Q2 2026, buying an estimated $2.58K and bringing the position to 96,300 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3583.

Deutsche Bank first reported a position in HRTX in Q1 2014 and has held it in 50 quarters since. The position peaked at $36.7M in Q2 2018. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Deutsche Bank held 96,300 shares of Heron Therapeutics worth $41.4K as of Q2 2026.
  • Deutsche Bank bought 3,219 Heron Therapeutics shares in Q2 2026, an estimated $2.58K.
  • Heron Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3583 holding.
  • Deutsche Bank first reported a position in Heron Therapeutics in Q1 2014 and has held it in 50 quarters since.
  • Deutsche Bank's Heron Therapeutics position peaked at $36.7M in Q2 2018.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.